drug summary · 2 NDC codes
BRIXADI 8 mg/.16mL
BUPRENORPHINE
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | BUPRENORPHINE |
|---|---|
| active ingredients | BUPRENORPHINE |
| dosage form | INJECTION |
| route | SUBCUTANEOUS |
| strength | 8 mg/.16mL |
| marketing status | NDA |
| DEA schedule | CIII |
| application number | NDA210136 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Braeburn Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 58284-208 | — |
| 58284020801 | — |
Other BUPRENORPHINE products
6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- BRIXADI 128 mg/.36mLINJECTION · Braeburn Inc.
- BRIXADI 16 mg/.32mLINJECTION · Braeburn Inc.
- BRIXADI 24 mg/.48mLINJECTION · Braeburn Inc.
- BRIXADI 32 mg/.64mLINJECTION · Braeburn Inc.
- BRIXADI 64 mg/.18mLINJECTION · Braeburn Inc.
- BRIXADI 96 mg/.27mLINJECTION · Braeburn Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.